# Cyto-Facto

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cyto-facto

- Industry: Biotechnology
- Headquarters: Kobe-shi, Japan
- Website: www.cytofacto.com
- Total disclosed funding: $16M
- Latest round: Series B (Jun 13, 2025)
- Investors on record: 9

## About

Founded in 2022 and based in Hogyo, Japan, Site Fact Co., trading under the name Cyto-Facto Inc., operates as a gene cell preparations company it provides CMO/CDMO business, contract quality testing, and manufacturing consulting for gene cell preparations. As of 2023, the company is led by its CEO, Shin Kawamata. In August 2023, Cyto-Facto Inc. raised venture debt financing of 300 million yen from financial institutions. 

The company offers contract manufacturing services for commercial gene and cell preparations (CMO business), process development for gene and cell preparations, as well as contract manufacturing services for clinical trial products (CDMO business). Additionally, they provide contract quality testing for gene and cell products, manufacturing services for gene and cell products, and consulting services. 

The company plans to use the August 2023 funding to expand the CMO and CDMO operations both within Japan and internationally. Additionally, they aim to diversify their business offerings by venturing into the virus vector sector.

## Funding rounds

- Series B, Jun 13, 2025, $8.3M — Sumitomo Corporation, Asahi Kasei Corporate Venture Capital, MPower Partners, Fujifilm
- Series A, Apr 22, 2024, $7.6M — SMBC Venture Capital, Mizuho Capital, Mitsubishi, Asahi Kasei Corporate Venture Capital, D3 LLC, MPower Partners, Kobe University Capital

## Investors

- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series A
- Mizuho Capital (https://capitalatlas.ai/funds/mizuho-capital) — Series A
- Mitsubishi — Series A
- Asahi Kasei Corporate Venture Capital — Series A, Series B
- D3 LLC (https://capitalatlas.ai/funds/d3-llc) — Series A
- MPower Partners — Series A, Series B
- Kobe University Capital (https://capitalatlas.ai/funds/kobe-university-capital) — Series A
- Sumitomo Corporation — Series B
- Fujifilm — Series B